Research Progress on Drug-Resistant Bacteria

Author(s): Zhang Xiaoping, Yu Xiangmin

More and more microorganisms have developed drug resistance with the use of antibiotics, and some microorganisms have multi-drug resistance. Therefore, bacterial resistant antibiotic is a serious problem to treating infectious diseases in recent years all over the world. This paper briefly reviews the research progress of bacterial resistance mechanisms all over the world, and provides theoretical basis for exploring effective prevention measures and rational use antibiotics in clinical.

Drug-Resistant Bacteria, Antibiotics, Drug Resistance Mechanism, Multi-Drug Resistance

1. Ministry of Health of the People's Republic of China. Health Office [2008] 130 Notice of the General Office of the Ministry of Health on Strengthening Hospital Infection Control of Multi-drug-Resistant Bacteria [Z]. Beijing: Ministry of Health of the People's Republic of China, 2008.
2. Wang Haodong, Wang Wei, Wang Yongqiang, et al. Clinical investigation of acquired bacterial infection in intensive care unit[J]. Chinese Journal of Nosocomiology, 2004(02): 151-153.
3. Fu Mengqing. Study on bacterial resistance and syndrome in hospitalized patients in Dongzhimen Hospital for 5 years.
4. D’Costa V M, WaglechnerN, Pawlowski IA, et al. antibiotic resistance is ancient[J]. Nature, 2011, 477(7365) :457-461.
5. Bhullar K, WaglechnerN, Pawlowski IA, et al. antibiotic resistance is prevalent in an isolated cave microbiome [J]. PloS One, 2012, 7 (4) :e34953.
6. Tadesse D A, Zhao S, Tong E, et al. Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950-2002[J]. Emerging Infections Diseases, 2012, 18(5) :741-749.
7. Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. [J]. Current Opinion in Microbilogy, 2010, 13:558-564.
8. Hernández-Sarmiento JM, Martinez-Neqrete MA, Castrillón-Velilla DM, et al. Thin layer agar represents a cost-effective Alternative for the rapid diagnosis of multi-drug resistant tubereulosis. Rev Salud Publiea(Boqota). 2014,16(1):90-102.
9. Török ME. Chantratita N, Peacock SJ. Bacterial gene loss as a mechanism for gain of antimicrobial resistance. Curr Opin Microbiol. 2012, 15(5):583-587.
10. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009,360(5): 439-443.
11. Huang Xiangning, Liu Hua. Analysis of pathogen distribution and drug resistance in intensive care unit[J]. Journal of North Sichuan Medical College, 2008, 23(4): 386-388.
12. Wang Jin, Xiao Yonghong, Mohnarin 2006~2007 Annual Report: Drug Resistance Test Results of Gram-positive Bacteria[J]. Chinese Journal of Antibiotics, 2008, 33(10): 592-596.
13. Wang Fu, Zhu Demei, Hu Fupin, et al. 2008 CHITE [J]. Chinese Journal of Infection and Chemistry, 2009, 9(5): 321-329.
14. Zhu Demei, Hu Fupin, Wang Fu, et al. Monitoring of drug resistance of CHINE in China in 2007[J]. Chinese Journal of Infection and Chemotherapy, 2009, 9(3): 168-171.
15. CDC, Staphylococcus aureus with reduced susceptibility to vancomycin-Illinois, 1999[J]. Morb Mortal Wkly Rep, 2000, 48(51):1165-1167.
16. Sievert DM, Rudrik JT, Patel JB, et al. Vancomycin resistant Staphylococcus aureus in the United States, 2002-2006[J]. Clin Infect Dis, 2008,46(5):668-674.
17. CDC, Brief report: vancomycin-resistant Staphylococcus anreus New York, 2004[J]. Morb Mortal Wkly Rep,2004,53(15):322-323.
18. Diekema DJ, BootsMillerBJ, Vaughn TE, et al. Antimicrobial resist.ance trends and outbreak frequency in United States hospitals[J]. Clin Infect Dis, 2004, 38(1):78-85.
19. Paterson DL, Bonomo RA. Extended-spectnum beta-lactamases:a clinical update[J]. Clin Microbiol Rev, 2005, 18(4):657-686.
20. Zhuo Chao, Suo Danhong, Zhu Demei, et al. Monitoring of drug resistance of Escherichia coli and Klebsiella in 2007 [J]. Chinese Journal of Infection and Chemotherapy, 2009, 9(3): 185- 188.
21. Bian Fengzhi, Yuan Guangying, Detection and drug resistance monitoring of extended-spectrum β-lactamase of Escherichia coli and Klebsiella pneumoniae[J]. International Journal of Laboratory Medicine, 2008, 29( 6): 484-486.
22. Ni Yuxing, Wang Jinliang, Xu Yingchun, et al. Antimicrobial susceptibility test specification [M]. 2nd ed. Shanghai Science and Technology Press, 2009.
23. Jiang Tao, Luo Yongai. Clinical investigation of hospital-acquired Acinetobacter baumannii pneumonia[J]. Chinese Journal of Nosocomiology 2002, 12(4): 265-267.
24. Dong Xiaoqin, Zhang Honghe, Zhou Tianmei, et al. Study on homology of carbamycin-resistant Acinetobacter baumannii in critically ill patients[J]. Chinese Journal of Antibiotics, 2007, 19(1): 56-58.
25. Wang Ya, Zhu Huadong. Mechanism of drug resistance of Acinetobacter baumannii and its treatment progress[J]. Chinese Journal of Emergency Medicine, 2017, 26(7): 834-838.
26. Zhai Zuhuang, Qin Ling. Research progress on drug resistance-related genes of Pseudomonas aeruginosa in China from 2003 to 2007[J]. Modern Practical Medicine, 2008,20(6):413-415.
27. Li Xingjun, Li Yan, Liu Min, et al. Retrospective analysis of multidrug-resistant bacteria in nosocomial infections[J]. Journal of Xiangfan Vocational and Technical College, 2008, 7(2): 22-24.
28. Su Yuyan. Current status and countermeasures of bacterial resistance research[J]. CTM, 2008, 8(9): 1648-1650